“Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients by combining the power of Seagen’s antibody-drug conjugate technology with the scale and strength of Pfizer’s capabilities and expertise," says Pfizer Chairman and CEO Albert Bourla, PhD.

Researchers across the pond have developed and externally validated an AI model that can predict flareups of ulcerative colitis. 

By now it’s a difficult-to-dispute likelihood: AI won’t replace doctors making diagnoses, but doctors who use AI will displace doctors who don’t use AI. The hypothesis gets a fresh airing out from the vantage point of the general public. 

The project may inform theories of human neurodevelopment as dynamically as it advances computer and data science.

An outbreak of Marburg virus disease has been confirmed in Equatorial Guinea for the first time, the World Health Organization (WHO) reported.

More than 90% of local infections in Beijing between Nov. 14 and Dec. 20, 2022, were BA.5.2 and BF.7, two existing Omicron sub-variants of COVID-19.

The company is pursuing treatments that could target diabetes and obesity in a pill form.

Johnson & Johnson has discontinued its Mosaico clinical trial that aimed to protect against HIV after its Phase 3 study revealed the regiment was safe but ineffective.